"Microgravity" as a unique and useful stem cell culture environment for cell-based therapy
- PMID: 31890760
- PMCID: PMC6933149
- DOI: 10.1016/j.reth.2019.03.001
"Microgravity" as a unique and useful stem cell culture environment for cell-based therapy
Abstract
Cell-based therapy using mesenchymal stem cells or pluripotent stem cells such as induced pluripotent stem cells has seen dramatic progress in recent years. Part of cell-based therapy are already covered by public medical insurance. Recently, researchers have attempted to improve therapeutic effects toward various diseases by cell transplantation. Culture environment is considered to be one of the most important factors affecting therapeutic effects, in particular factors such as physical stimuli, because cells have the potential to adapt to their surrounding environment. In this review, we provide an overview of the research on the effects of gravity alteration on cell kinetics such as proliferation or differentiation and on potential therapeutic effects, and we also summarize the remarkable possibilities of the use of microgravity culture in cell-based therapy for various diseases.
Keywords: CNS, central nervous system; ISS, International Space Station; MSCs, mesenchymal stem cells; Microgravity; RCCS, rotary cell culture system; Regenerative therapy; Stem cells; cMSCs, cranial bone-derived MSCs.
© 2019 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.
Figures
References
-
- Muroi K., Miyamura K., Okada M., Yamashita T., Murata M., Ishikawa T. Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade Ⅲ or Ⅳ acute graft-versus-host disease: a phase Ⅱ/Ⅲ study. Int J Hematol. 2016;103:243–250. - PubMed
-
- Le Blanc K., Rasmusson I., Sundberg B., Götherström C., Hassan M., Uzunel M. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439–1441. - PubMed
-
- Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371:1579–1586. - PubMed
-
- Shichinohe H., Kawabori M., Iijima H., Teramoto T., Abumiya T., Nakayama N. Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke. BMC Neurol. 2017;17:179. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
